Amino-CR and Moxetumomab pasudotox
Determining the interaction of Amino-CR and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chromium picolinate
Brand name: Cr-GTF, CRM, Chromium GTF
Synonyms: Chromium picolinate, Chromium
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amino-CR-Moxetumomab Pasudotox-tdfk
- Amino-CR-Moxetumomab pasudotox-tdfk Intravenous
- Amino-CR-Moxifloxacin
- Amino-CR-Moxifloxacin (Systemic)
- Amino-CR-Moxifloxacin Hydrochloride
- Amino-CR-Moxifloxacin Injection
- Moxetumomab pasudotox-Amino-Opti-C
- Moxetumomab pasudotox-Aminobenzoate potassium
- Moxetumomab pasudotox-Aminocaproic
- Moxetumomab pasudotox-Aminocaproic acid
- Moxetumomab pasudotox-Aminocaproic Acid Injection
- Moxetumomab pasudotox-Aminocaproic Acid Injection Solution